- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
- Locations
-
- CHU Hôpital Gui de Chauliac Service de Neurologie B Montpellier, France
Clinical trial condition
Multiple Sclerosis, Relapsing-Remitting
Explore clinical trials studying Multiple Sclerosis, Relapsing-Remitting. Study availability and eligibility vary by location and protocol.
455 public trials
46 recruiting studies
Multiple Sclerosis, Relapsing-Remitting trial results
NCT02647502
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
- Locations
-
- Johns Hopkins University Baltimore, Maryland, United States
NCT02247310
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
- Locations
-
- Many Locations, Austria
- Many Locations, Belgium
- Many Locations, Bosnia and Herzegovina
- Many Locations, Croatia
NCT02598167
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
- Locations
-
- Hospital Sant Joan Despi Moises Broggi; Servicio de Neurología Sant Joan Despí, Barcelona, Spain
- Hospital Universitario Marques de Valdecilla; Servicio de Neurología Santander, Cantabria, Spain
- Hospital General de Castellon; Servicio de Neurología Castellon, Spain
- Hospital Universitari Arnau de Vilanova de Lleida; Servicio de Neurología Lleida, Lerida, Spain
Completed
Study of the Effect of BG00012 on MRI Lesions and Pharmacokinetics in Pediatric Subjects With RRMS
NCT02410200
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
- Locations
-
- Research Site San Bernardino, California, United States
- Research Site Ghent, Belgium
- Research Site Sofia, Bulgaria
- Research Site Hradec Králové, Czechia
NCT03302442
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
- Locations
-
- Nantes University Hospital Nantes, France
Completed
High-Dose Immunosuppression and Autologous Transplantation for Multiple Sclerosis (HALT MS) Study
NCT00288626
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
- Locations
-
- Ohio State University School of Medicine Columbus, Ohio, United States
- Baylor College of Medicine Houston, Texas, United States
- M.D. Anderson Cancer Center; Transplant site, please contact Baylor College of Medicine Houston, Texas, United States
- Fred Hutchinson Cancer Research Center Seattle, Washington, United States
NCT01431937
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
- Locations
-
- GSK Investigational Site Randwick, New South Wales, Australia
- GSK Investigational Site Adelaide, South Australia, Australia
- GSK Investigational Site Nedlands, Western Australia, Australia
NCT01466322
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
- Locations
-
- GSK Investigational Site Herston, Queensland, Australia
NCT01416363
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
- Locations
-
- GSK Investigational Site Randwick, New South Wales, Australia